13.10.2006 – 08:22

Intercell AG

Intercell AG wins EUROPEAN BIOTECHNICA AWARD 2006

  ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
  the content of this announcement.

Intercell AG was honoured with the first price in the final round of
the Biotechnica Award 2006 during yesterday’s ceremony at the Biotech
CEO Conference in Zürich. The Biotechnica Award, endowed with 40,000
Euros, is awarded by the Deutsche Messe AG for the fourth time to
European biotech and life science companies in the fields of
biotechnology and related life sciences with proven success in
launching innovative products or services, or in implementing
promising new business concepts.

The jury including experts from science and industry as well as
representatives of the capital markets, has selected three finalists
from 16 outstanding candidates from eight countries in the first
round. Alongside scientific innovation, the jury was judging criteria
such as commercial viability, market relevance, marketing concepts
and business models.

The 2nd price was awarded to Genmab S/A, a biotechnology company
located in Denmark, and the 3rd prize was awarded to the German
biotech company amaxa GmbH.

Conditions for Applicants:

•       Market presence of at least two years
•       At least 30 to 350 employees (maximum)
•       Annual turnover of up to 50 million euros
•       Independent business (maximum 25 percent share of company capital held
        by large company, except for venture-capital companies)
•       Successful activities on the biotechnology/life sciences markets

For more information, please visit: www.biotechnica.de/award_e

end of announcement                               euro adhoc 13.10.2006 08:21:21

Further inquiry note:

Intercell AG
Mag. Katharina Wieser
Head of Corporate Communications
Tel. +43 1 20620-303
kwieser@intercell.com

Branche: Biotechnology
ISIN: AT0000612601
WKN: A0D8HW
Börsen: Wiener Börse AG / official market